Transtema: Brighter Times Ahead - Redeye

Redeye maintains a positive view of Transtema following a Q2 beating our expectations. While the Q2 numbers were on the soft side as expected (yet better than expected), the most important takeaway is that the worst likely is over, and Transtema enters 2025 with a solid order backlog. Although we somewhat lower our expectations in Norway, we retain our positive view of 2025.

Länk till analysen i sin helhet: https://www.redeye.se/research/1030352/transtema-brighter-times-ahead?utm_source=finwire&utm_medium=RSS